Visionaries look to the future—and see infinite possibility.
They challenge the status quo—and make the impossible possible.

They boldly imagine a better world – and lead the charge to create it.

The Leukemia & Lymphoma Society was built on that same vision - of a better world - one without blood cancers.

I am a visionary; I have a vision for a world without cancer, but I need your help.

This year, I’m proud to be a part of the Leukemia & Lymphoma Society’s (LLS) Student Visionaries of the Year Campaign, working to raise as much as possible for LLS’s mission.

I decided to dedicate my time to LLS and SVOY because I want to help those who have been given the worrisome diagnosis of blood cancer. This mission is important to me because of its commitment to advance research and treatment, and to support patients physically and financially. I want to be a part of changing the future and having a vision of a world without blood cancer. I am inspired by the strength of those who keep fighting. I commit to fight along with them through being a part of this campaign.

As a global leader in the fight against blood cancer, LLS:

• Funds cutting-edge research leading to breakthroughs in immunotherapy, genomics and personalized medicine that are improving and saving the lives of patients
• Provides free education and support for blood cancer patients and families, including personalized, one-on-one support, assistance with identifying and enrolling in clinical trials, and more.
• Mobilizes thousands of advocates to drive policy changes that accelerate the development of new cancer treatments and break down barriers to care.

Please consider joining this fight by making a donation. All donations are greatly appreciated and tax-deductible. Please visit my website often and tell friends who would also like to donate!

Thanks to your support, my efforts will help ensure this generation is the last to see cancer.

On behalf of blood cancer patients everywhere, thank you!

For more information about LLS, please visit www.lls.org.